The current gold standard for weight loss research. 20–25% average body weight reduction in clinical trials.
Tirzepatide activates both GLP-1 and GIP receptors — a dual mechanism that consistently produces superior results to single-receptor compounds. The SURMOUNT-1 clinical trial demonstrated average 22.5% body weight reduction at the highest studied dose.
PEPTARA Health supplies research-grade Tirzepatide as lyophilized powder with full third-party purity verification and mass spectrometry confirmation.
| Vial Size | Price | Best For |
|---|---|---|
| 5mg | $28 | Starting protocol (weeks 1–8) |
| 10mg | $48 | Standard 8–16 week protocol |
| 15mg | $68 | Extended protocol support |
| 30mg | $115 | Bulk research supply — best value/mg |
All prices include Certificate of Analysis. Cold-chain shipping from North Carolina.
| Factor | Tirzepatide | Semaglutide |
|---|---|---|
| Receptors | GLP-1 + GIP | GLP-1 only |
| Avg. weight loss | 20–25% | 15–18% |
| Starting price | $28 | $30 |
| Evidence level | ★★★★★ Strong | ★★★★★ Extensive |
Questions? Text Sarah at (704) 605-9477 — we respond within 2 hours.
Clinical research shows Tirzepatide produces greater average weight loss (20-25%) compared to Semaglutide (15-18%), due to its dual GIP/GLP-1 mechanism.
Yes. Research-grade Tirzepatide sold as a research compound is legal to buy, possess and receive in all 50 US states.
Every batch is verified to 99%+ HPLC purity with mass spectrometry confirmation. COA included with every order.
Store lyophilized powder refrigerated at 2-8°C or frozen at -20°C for long-term. Once reconstituted, refrigerate only — never freeze — and use within 30 days.
